Related references
Note: Only part of the references are listed.Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
Joan W. Miller et al.
OPHTHALMOLOGY (2013)
Vascular Endothelial Growth Factor in Plasma and Vitreous Fluid of Patients with Proliferative Diabetic Retinopathy Patients after Intravitreal Injection of Bevacizumab
Yan Ma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Antiangiogenic Shift in Vitreous after Vitrectomy in Patients with Proliferative Diabetic Retinopathy
Shigeo Yoshida et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Intraocular VEGF Level as a Risk Factor for Postoperative Complications after Vitrectomy for Proliferative Diabetic Retinopathy
Yoshihiro Wakabayashi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy
Mojca Globocnik Petrovic et al.
ACTA OPHTHALMOLOGICA (2010)
Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
K. Matsuyama et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Reasons for and Management of Postvitrectomy Vitreous Hemorrhage in Proliferative Diabetic Retinopathy
Hua Yan et al.
CURRENT EYE RESEARCH (2010)
Managing diabetic retinopathy
Zoe Ockrim et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Microincision Vitrectomy Surgery and Intravitreal Bevacizumab as a Surgical Adjunct to Treat Diabetic Traction Retinal Detachment
Yusuke Oshima et al.
OPHTHALMOLOGY (2009)
Vascular endothelial growth factor and diabetic complications
Barbara Wirostko et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2008)
Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines
H. Funatsu et al.
EYE (2007)
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Rafael Simo et al.
CURRENT DIABETES REVIEWS (2006)
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy
H Itakura et al.
OPHTHALMOLOGY (2004)
Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II
H Funatsu et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Share Paper
